These results demonstrate the conservation of the molecular signature of the autophagic defects, observed in vitro and in the experimental models, in the AD brain, and support the occurrence of acetylated tau rerouting to LE/MVB in AD patients’ brains. Here, MAPT is linked to Alzheimer disease.